Please be aware that this is a machine translation from French to English. AVICENN is not responsible for incorrect or inaccurate translations but welcomes suggestions for reformulation.

VeilleNanos - Nanomedicine: promises and risks

Nanomedicine: promises and risks


Nanomedicine, transhumanism and NBIC in the medical field: promises and risks

By AVICENN – Last updated September 2023

The acronym NBIC refers to the convergence of nanotechnologies (N) with biotechnologies (B), information sciences (I), and cognitive sciences (C).

Some quotes as a preamble:

“In the utopian hope of being able to conquer death and suffering through the limitless power of our science, all of us, doctors, patients, health authorities, politicians… get drunk on the uninterrupted flow of discoveries that biotechs like to announce with great fanfare. Drunkenness sometimes leads to absurdity (…). This leads to a real problem ofhealth equity: all other things being equal, patients who can benefit from sophisticated treatments will receive more resources from the national solidarity than those requiring “human” care, considered less prestigious. – Bruno Falissard, “ Medicine is the best alibi for technoscientific hubris “, Le Monde, September 2022.

“In the 1960s, during the presidency of Richard Nixon, the U.S. administration had decreed a “war on cancer.” The promise was that “in 10 years, we will have won”. Lots and lots of money was spent. Not everything has been in vain, but this war has obviously not been won”. – Jean-Marc Lévy-Leblond, “There is no democratic control of science,” Critical Science, December 2015.

“New curative advances still allow those without excellent intrinsic longevity to nibble away a few years of life after age 65. However, these results are nothing compared to the preventive measures known as hygienic-dietary rules. These can be summarized as three: regular walking, caloric restriction and smoking cessation. Their results are far superior to any pharmacological or instrumental interventions in most neurodegenerative, tumor, cardiovascular, infectious and locomotor pathologies“. – Luc Perino, excerpt from “Refusing death can be deadly,” in For Health Reasons – Medicine and the Facts, July 8, 2015.

Promises of nanomedicine and NBICs in the medical field

General or synthetic documents on nanomedicine

In French :

In English:

More "specialized" or focused documents

In French :

→ English:

Risks, regulation and societal issues raised by nanomedicine, transhumanism and NBIC in the medical field

Explore the bibliography


Any questions or comments? This information sheet compiled by AVICENN is intended to be completed and updated. Please feel free to contribute.

Upcoming Nano Agenda

Managing the risks associated with nanomaterials (CEA, Grenoble)
  • Awareness-raising aimed at personnel in contact with nanomaterials during research, formulation, production, maintenance, cleaning, upkeep, etc., as well as safety coordinators or engineers, facility managers, heads of laboratories where nanoparticles are handled.
  • Organizers: INSTN Grenoble (CEA)
  • On the agenda: potential impact on health; metrology and protection; control of potential risks associated with nanomaterials; consideration of societal aspects.
  • Website:
Nanomaterials and Health (ANSES, Maisons-Alfort)
Dialogue Committee
Nanoparticles NPC-24 (ETH, Zurich)
  • 27th ETH Nanoparticles Conference
  • Organizer: ETH Zurich
  • From June 10 to June 14, 2024
  • Website:

This sheet was originally created in February 2019

Our monitoring, information and actions need you to continue !